Cardiac Safety Services
Almost Everyone Has to Do Thorough QT Testing. We’ve Done More of It Than Anyone Else.
Many new drugs, especially those with systemic bioavailability, have the potential to cause unexpected QT/QTc interval prolongation and arrhythmias.
Cetero has the experience to ensure that if they do, their severity will be discovered and documented while ensuring participant safety. Our physicians, nurses and clinical teams have conducted over 10,000 cardiac safety trials, including more than 55 definitive TQT trials – more than any other CRO, anywhere. We have successfully recruited over 5,300 cardiac safety trial participants over the past two years.
We have a spacious state-of-the-art facility fully equipped to perform cardiac safety trials. With nearly 1,400 beds – including 120 dedicated hospital beds at this site – we have the largest bed capacity of any CRO. This means we can accommodate large single study groups for quicker study turnaround. In fact, our largest enrollment of a single cohort in a TQT trial included 70 participants, while our largest TQT trial included 280 subjects.
Cetero’s standards are exacting and stringent. Our cardiac safety team follows clearly documented quality control protocols to ensure consistent, accurate and safe results. At the same time, we’re easy to work with, and we fully understand that you may have concerns that go beyond simply collecting the data to make critical decisions as early as possible in the drug development process.
Most sponsors don’t have a choice about doing QT testing. You do have a choice about where to do it. And you’ll be pleased to discover the difference it makes when you do it with Cetero. Find out today.
- 12-lead continuous ECG H-12 holter recording
- Electronic data capture system – study monitor
- Alliances with core central ECG labs
- Experience with Mortara H-12 and H-12+ holters and Mortara E-Scribe Software
- Telemetry
- Ambulatory blood pressure monitoring
